Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
61-75 of 2107 results
AbbVie forms two oncology-focused collaborations with CytomX and argenx
By PBR Staff Writer
Research-based biopharmaceutical firm AbbVie has entered into two oncology-focused collaborations with CytomX Therapeutics and argenx.
Contract Research & Services > Contract Research > News
Basilea signs deal with BARDA for phase 3 development of ceftobiprole antibiotic
By PBR Staff Writer
Basilea Pharmaceutica has signed an agreement worth $100m with the US Department of Health for the clinical phase 3 development of ceftobiprole antibiotic.
Contract Research & Services > Contract Research > News
Astex, Genentech partner to explore combination treatment for acute myeloid leukemia
By PBR Staff Writer
Astex Pharmaceuticals has formed a clinical trial collaboration with Genentech to explore a combination treatment for acute myeloid leukemia (AML).
Contract Research & Services > Contract Research > News
Compugen achieves preclinical milestone in cancer immunotherapy collaboration with Bayer
Compugen has achieved a first preclinical milestone for CGEN-15022 pursuant to its cancer immunotherapy collaboration with Bayer.
Contract Research & Services > Contract Research > News
Presage Biosciences extends research collaboration with Takeda to discover novel cancer drug combinations
Presage Biosciences has entered into a multi-year extension of its November 2014 research alliance with Takeda Pharmaceuticals Company.
Contract Research & Services > Contract Research > News
PsiOxus, Parker Institute for Cancer Immunotherapy plan to partner on tumor-specific immuno-gene therapy
PsiOxus Therapeutics and the newly launched Parker Institute for Cancer Immunotherapy have signed a Memorandum of Understanding (MoU) for a planned collaboration using the Tumor-Specific Immuno-Gene Therapy (T-SIGn) platform developed by PsiOxus.
Contract Research & Services > Contract Research > News
Allergan partners with Heptares to develop treatments for neurological disorders
By PBR Staff Writer
Allergan and Heptares Therapeutics have formed a global R&D and commercialization partnership for novel treatments in Alzheimer's and other neurological disorders.
Contract Research & Services > Contract Research > News
Forge Therapeutics and Active Motif form epigenetics research collaboration
By PBR Staff Writer
Forge Therapeutics and Active Motif said they will collaborate on epigenetic research related to the family of iron-containing lysine demethylases known as Jumonji KDMs.
Contract Research & Services > Contract Research > News
Blueberries could help fight Alzheimer's
'Super fruit' blueberries could play a vital role in preventing Alzheimer's. The fruit which has already been hailed for its ability to lower the risk of heart disease and cancer contains antioxidants that could prevent the devastating effects of this form of dementia.
Contract Research & Services > Contract Research > News
A step closer to a male birth control pill
For many years, scientists have attempted to formulate a male birth control pill, finally researchers at the University of Minnesota have made a significant breakthrough that may lead to a male contraceptive.
Contract Research & Services > Contract Research > News
Kalytera, Ramot at Tel Aviv University to study novel approach to treat osteogenesis imperfecta
Kalytera Therapeutics has signed a preclinical research agreement with Ramot at Tel Aviv University ("Ramot") to evaluate three Kalytera drug candidates to assess their potential ability to strengthen bone in persons with osteogenesis imperfecta ("OI"), a rare group of genetic disorders characterized by bones that are brittle and break easily.
Contract Research & Services > Contract Research > News
Tarantula venom could be used in painkillers
While most fear the sight of tarantulas let alone their deadly venom, it turns out toxins from some animals could actually have a therapeutic benefit.
Contract Research & Services > Contract Research > News
Beer could be used to fight cancer and disease
A key ingredient in beer could be used as medicine to fight disease. Hops, found in the alcoholic beverage which gives it its bitter taste, are surprisingly helpful to halt bacterial growth and disease.
Contract Research & Services > Contract Research > News
Netflix marathons might make you miserable
In 2015 users spent 10 billion hours watching Netflix, it is estimated that 61% of users binge-watch shows every few weeks. According to research by the University of Toledo these types of viewing habits could make you miserable and needs to be addressed.
Contract Research & Services > Contract Research > News
Inovio signs collaborative research deals with Wistar Institute for DNA-based immunotherapies
Inovio Pharmaceuticals has signed collaborative research agreements (CRAs) with the Wistar Institute for preventive and therapeutic DNA-based immunotherapy applications and products for cancers and infectious diseases developed by David B. Weiner, Ph.D., and his Wistar laboratory.
Contract Research & Services > Contract Research > News
61-75 of 2107 results